(Q39573471)

13 September 2017

title

Reprogramming cancer cells: back to the future (English)

1 reference

13 September 2017

J-Y Lang

1

1 reference

13 September 2017

Y Shi

series ordinal

2

1 reference

13 September 2017

Y E Chin

series ordinal

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

6 August 2012

1 reference

13 September 2017

1 reference

13 September 2017

volume

32

1 reference

13 September 2017

issue

18

1 reference

13 September 2017

page(s)

2247-2248

1 reference

Upping the ante: recent advances in direct reprogramming

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Reprogramming of a melanoma genome by nuclear transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Generation of iPSCs from cultured human malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Defined factors induce reprogramming of gastrointestinal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

iPSCs from cancer cells: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Gastric cancer originating from bone marrow-derived cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Sustained loss of a neoplastic phenotype by brief inactivation of MYC

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

Acute promyelocytic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.349

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.349

1 reference

13 September 2017

1 reference